JPH05508653A - 水性溶媒に可溶化し得る疎水性医薬の有効成分をベースとする組成物、その製法、及び特に医薬分野におけるその使用 - Google Patents

水性溶媒に可溶化し得る疎水性医薬の有効成分をベースとする組成物、その製法、及び特に医薬分野におけるその使用

Info

Publication number
JPH05508653A
JPH05508653A JP91512552A JP51255291A JPH05508653A JP H05508653 A JPH05508653 A JP H05508653A JP 91512552 A JP91512552 A JP 91512552A JP 51255291 A JP51255291 A JP 51255291A JP H05508653 A JPH05508653 A JP H05508653A
Authority
JP
Japan
Prior art keywords
group
sulfate
type
glycoside
lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91512552A
Other languages
English (en)
Japanese (ja)
Inventor
シエデイツド，ルイ
ルフランシエ，ピエール
Original Assignee
バクシン・フランス・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9009172A external-priority patent/FR2664813B1/fr
Application filed by バクシン・フランス・エス・アー filed Critical バクシン・フランス・エス・アー
Publication of JPH05508653A publication Critical patent/JPH05508653A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP91512552A 1990-07-18 1991-07-18 水性溶媒に可溶化し得る疎水性医薬の有効成分をベースとする組成物、その製法、及び特に医薬分野におけるその使用 Pending JPH05508653A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9009172A FR2664813B1 (fr) 1990-07-18 1990-07-18 Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
FR9101497A FR2672496B3 (fr) 1990-07-18 1991-02-08 Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
PCT/FR1991/000595 WO1992001475A1 (fr) 1990-07-18 1991-07-18 Compositions a base de principes actifs de medicaments hydrophobes solubilisables dans un solvant aqueux

Publications (1)

Publication Number Publication Date
JPH05508653A true JPH05508653A (ja) 1993-12-02

Family

ID=26228157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91512552A Pending JPH05508653A (ja) 1990-07-18 1991-07-18 水性溶媒に可溶化し得る疎水性医薬の有効成分をベースとする組成物、その製法、及び特に医薬分野におけるその使用

Country Status (6)

Country Link
EP (1) EP0539457A1 (fr)
JP (1) JPH05508653A (fr)
AU (1) AU8282991A (fr)
CA (1) CA2087536A1 (fr)
FR (1) FR2672496B3 (fr)
WO (1) WO1992001475A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011092A1 (fr) * 1994-04-07 1997-03-27 Nippon Shinyaku Co., Ltd. Derives de phosphates de cyclosporine et composition medicinale
JP2003502388A (ja) * 1999-06-22 2003-01-21 コリクサ コーポレイション モノホスホリルリピドａの水性免疫学的アジュバント組成物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692149B1 (fr) * 1992-06-12 1995-06-09 Vacsyn France Sa Composition adjuvante de l'immunite humorale et a mediation cellulaire n'induisant pas de reponse vis-a-vis de determinants auto-antigeniques.
FR2706772A1 (en) * 1993-06-22 1994-12-30 Vacsyn Sa Prevention and treatment of septic syndrome with an immunosuppressant, in particular cyclosporin.
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
DK1096954T3 (da) * 1998-07-14 2005-01-31 Wyeth Corp Adjuvans- og vaccinesammensætninger indeholdende monophosphoryllipid A
US6121430A (en) * 1998-12-28 2000-09-19 University Of Iowa Research Foundation Regiospecific synthesis of glucose-based surfactants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT709141A (fr) * 1963-11-08
US3808200A (en) * 1969-07-29 1974-04-30 Agriculture Hexitol,glucose and surcose esters of alpha-sulfo fatty acids
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
JPS62174094A (ja) * 1985-12-16 1987-07-30 Ss Pharmaceut Co Ltd α．α―トレハロース誘導体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011092A1 (fr) * 1994-04-07 1997-03-27 Nippon Shinyaku Co., Ltd. Derives de phosphates de cyclosporine et composition medicinale
JP2003502388A (ja) * 1999-06-22 2003-01-21 コリクサ コーポレイション モノホスホリルリピドａの水性免疫学的アジュバント組成物

Also Published As

Publication number Publication date
FR2672496A1 (fr) 1992-08-14
EP0539457A1 (fr) 1993-05-05
AU8282991A (en) 1992-02-18
CA2087536A1 (fr) 1992-01-19
FR2672496B3 (fr) 1993-05-28
WO1992001475A1 (fr) 1992-02-06

Similar Documents

Publication Publication Date Title
JP3714683B2 (ja) 抗リウマチ剤
Nowotny Beneficial effects of endotoxins
JPS61246134A (ja) 腸管吸収化合物および複合体
US4844894A (en) Method of inhibiting the onset of septicemia and endotoxemia
EP0003833B2 (fr) Dérivés d'antigène, procédé pour leur préparation, compositions pharmaceutiques les contenant
JPS58222027A (ja) 精製無毒化エンドトキシンを含有する抗腫瘍組成物
CA1242982A (fr) Derives immunostimulants et leur procede de preparation
HU185314B (en) Process for producing water-soluble immunostimulant glyco-proteins from klebsiella pneumoniae
Wiltrout et al. Immunomodulation of natural killer activity by polyribonucleotides
JPH05508653A (ja) 水性溶媒に可溶化し得る疎水性医薬の有効成分をベースとする組成物、その製法、及び特に医薬分野におけるその使用
WO1993005774A1 (fr) Complexes d'antibiotiques d'anthracycline et d'acides gras polyinsatures dans des emulsions de lipides
US5250296A (en) Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
JPS6412279B2 (fr)
JPH03503647A (ja) 黒色腫の治療のためのｉｌ‐２とｄｔｉｃとの組合せ療法
EP0948359A1 (fr) Compositions d'oligosaccharide lipophile antibiotique et d'albumine
CN103154012B (zh) 聚丙基醚亚胺的糖树状聚体
EP0165123A2 (fr) Dérivés lipophiles de muramylpeptides ayant des propriétés d'activation des macrophages, compositions les contenant et procédé pour les obtenir
US6267968B1 (en) MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
HU185315B (en) Siliconpolymer compositions for treating textile materials
JPH05500817A (ja) マイコバクテリウムケロナエの極性糖ペプチド脂質に基づく免疫刺激薬
JP4366081B2 (ja) 高度に精製されたアンチエンドトキシン化合物
DD145274A5 (de) Verfahren zur darstellung neuer verbindungen des muramylpeptidtyps
KR100266929B1 (ko) 약학적 라이신-함유 폴리펩티드 조성물 및 그의 사용방법
IE60490B1 (en) Freeze-Dried Pharmaceutical Compositions of Phenylquinoline carboxylic acids
FR2672495A1 (fr) Compositions immunomodulatrices, a base de produits comportant au moins un groupe phosphate ou sulfate, et un gel d'un compose d'aluminium.